Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

New Rhein Healthcare

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 9
Average round size
info
The average size of a deal this fund participated in
$17M
Portfolio companies 8
Rounds per year 0.69
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.11
Exits 3
Key employees 3
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Medical
  • Health Care
  • Therapeutics
  • Commercial
Summary

In 2010 was created New Rhein Healthcare, which is appeared as VC. The venture was found in North America in United States. The main office of represented VC is situated in the Chicago.

Among the most popular portfolio startups of the fund, we may highlight Neuraptive Therapeutics, Biocartis, Chase Pharmaceuticals. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Medical Device, Medical.

The overall number of key employees were 3.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the New Rhein Healthcare, startups are often financed by Johnson & Johnson Development Corporation, Debiopharm Group, Aescap Venture. The meaningful sponsors for the fund in investment in the same round are Valiance Asset Management, RMM, Philips Venture Capital Fund. In the next rounds fund is usually obtained by PMV Tina Fund, Johnson & Johnson Development Corporation, Wellcome Trust.

The top amount of exits for fund were in 2016. The real fund results show that this VC is 30 percentage points more often commits exit comparing to other companies. The high activity for fund was in 2018. Comparing to the other companies, this New Rhein Healthcare performs on 21 percentage points more the average number of lead investments. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of New Rhein Healthcare:
Typical Co-investors
New Rhein Healthcare is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after New Rhein Healthcare:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aquitaine Creation Aquitaine, France, Pessac
Charter Venture Group Houston, Texas, United States
Ferry Venture Capital China, Shanghai
GCI Capital Canada, Ontario, Toronto
Genopole Évry, France, Ile-de-France
Joyvio Group Beijing, Beijing, China
Mapleblock Capital -
Singulariteam Israel, Tel Aviv, Tel Aviv District
Sleepz Berlin, Berlin, Germany

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Corsair Pharma

$23M20 Sep 2023 Sunnyvale, California, United States

Theranica

Biotechnology
Medical
Therapeutics
$45M29 Aug 2022 Israel, North District, Israel

Health Care
Medical
Men's
$7M06 Oct 2020 Israel, North District, Israel

American Injectables

Manufacturing
Medical
Pharmaceutical
$10M24 Sep 2020 Tampa, Florida, United States

Neuraptive Therapeutics

Biotechnology
Commercial
Health Care
Therapeutics
$11M19 Dec 2018 Colorado, United States

Neuraptive Therapeutics

Biotechnology
Commercial
Health Care
Therapeutics
$1M06 Sep 2017 Colorado, United States

Softhale

Biotechnology
Medical
Medical Device
30 Nov 2016 Diepenbeek, Limburg, Belgium

Chase Pharmaceuticals

Biotechnology
Health Care
Medical
$21M12 May 2014 District of Columbia, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent New Rhein Healthcare?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 9
Average round size 17M
Rounds per year 0.69
Peak activity year 2020
Lead investments 4
Follow on index 0.11
Exits 3
Group Appearance index 0.56

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Corsair Pharma

$23M20 Sep 2023 Sunnyvale, California, United States

Theranica

Biotechnology
Medical
Therapeutics
$45M29 Aug 2022 Israel, North District, Israel

Health Care
Medical
Men's
$7M06 Oct 2020 Israel, North District, Israel

American Injectables

Manufacturing
Medical
Pharmaceutical
$10M24 Sep 2020 Tampa, Florida, United States

Neuraptive Therapeutics

Biotechnology
Commercial
Health Care
Therapeutics
$11M19 Dec 2018 Colorado, United States

Neuraptive Therapeutics

Biotechnology
Commercial
Health Care
Therapeutics
$1M06 Sep 2017 Colorado, United States

Softhale

Biotechnology
Medical
Medical Device
30 Nov 2016 Diepenbeek, Limburg, Belgium

Chase Pharmaceuticals

Biotechnology
Health Care
Medical
$21M12 May 2014 District of Columbia, United States
Crunchbase icon

Content report

The following text will be sent to our editors: